Everest Organics Ltd

Wed 2/09/2026,16:1:0 | BSE : EVERESTO

₹267.00-10.00 (-3.61%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 273.05

Previous Close

₹ 277.00

Volume

452

Mkt Cap ( ₹ Cr)

₹ 259.27

High

₹ 275.00

Low

₹ 265.05

52 Week High

₹ 536.40

52 Week Low

₹ 197.00

Book Value Per Share

₹ 78.87

Dividend Yield

₹ 0.00

Face Value

₹₹10.00

What's Your Call?

Collective community sentiment on Everest Organics Ltd

Your Vote -

Buy

66.67%

Hold

0.00%

Sell

33.33%

66.67%

6 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Everest Organics Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Everest Organics - Fixed The Cut-Off Date For The 33Rd Annual General Meeting Of The Company

    14 Aug 2026, 4:44PM Enclosed
  • Everest Organics - Fixes Book Closure For The 33Rd Annual General Meeting Of The Company

    14 Aug 2026, 4:42PM Enclosed
  • Everest Organics - The 33Rd Annual General Meeting (AGM) Of The Company Scheduled To Be Held On Wednesday, September 30, 2026

    14 Aug 2026, 4:38PM Enclosed
  • Everest Organics - Announcement under Regulation 30 (LODR)-Change in Directorate

    14 Aug 2026, 4:36PM Appointment of Mr. Subroto Banerjee as Additional Director of the Company in the Independent Category w.e.f. August 14, 2026
  • Everest Organics - Announcement under Regulation 30 (LODR)-Change in Directorate

    14 Aug 2026, 4:34PM Appointment of Mr. Srikanth Reddy Kolli as Additional Director in the Independent Category w.e.f. August 14, 2026
  • Everest Organics - Board Meeting Outcome for Outcome Of The Board Meeting Held Today

    14 Aug 2026, 4:27PM Enclosed
  • Everest Organics - Un-Audited Financial Results For The Quarter Ended June 30, 2026

    14 Aug 2026, 4:24PM Enclosed
  • Everest Organics - Board Meeting Intimation for Meeting Scheduled To Be Held On Friday, August 14, 2026

    6 Aug 2026, 3:32PM Everest Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and
  • Everest Organics - Announcement under Regulation 30 (LODR)-Allotment

    11 Jul 2026, 12:59PM The Board of Directors approved by way of Circular Resolution on July 11, 2026, the Allotment of 263157 fully paid-up equity shares of Rs. 10 each at
  • Everest Organics has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026

    9 Jul 2026, 7:20PM As of June 2026, 59.60% is owned by Promoters and 40.40% by Public. <p align=justify> Among Promoters holding, Indian Promoters holds 57.86% and Forei
  • Everest Organics - Announcement under Regulation 30 (LODR)-Cessation

    22 Jun 2026, 11:27AM Resignation of Ms. Shweta Singh from the position of Company Secretary & Compliance Officer of the Company w.e.f. June 22, 2026.

Key fundamentals

Evaluate the intrinsic value of Everest Organics Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 125.4121 117.8214 103.6287 97.2623 85.5772
Liabilities 125.4121 117.8214 103.6287 97.2623 85.5772
Equity 9.7105 9.7105 8 8 8
Gross Profit 19.8107 7.2229 10.9866 0.9298 6.4276
Net Profit 5.5465 -1.2903 0.1392 -0.1822 1.1437
Cash From Operating Activities 4.1819 -5.3769 16.4201 18.4179 13.7374
NPM(%) 2.82 -0.8 0.07 -0.09 0.57
Revenue 196.1577 159.479 197.2412 183.0484 200.0466
Expenses 176.347 152.2561 186.2546 182.1186 193.619
ROE(%) 7.24 -1.68 0.18 -0.23 1.49

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Everest Organics Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 874.00 0.44 22.05 152.41 -26.19 0.57
Lotus Eye Hospital and Institute Ltd 109.05 0.05 1542.57 555.37 0.39 0.00
Bharat Immunological and Biologicals Corporation Ltd 15.35 -1.29 0.00 1153.12 -39.50 0.00
Astec Lifesciences Ltd 572.25 -0.01 0.00 595.04 -363.14 0.00

Company Info

Everest Organics Limited, a company with its registered office at Hyderabad, was incorporated on 19th February, 1993. The company has subsequently obtained the certificate of commencement of business on 17th March, 1993. The factory of the company is situated at Aroor Village, Sadasivpet Mandal, Medak district, A.P. The unit is eligible for incentives like State Subsidy, Sales Tax deferment and Power Tariff etc., as the unit is being located in Notified Backward Area. The main objects of the company is to carry on the business of manufacturing, selling of bulk drugs and formulations, which are fully set out in its Memorandum and Articles of Association and are also mentioned below in this prospectus. M/s Everest Organics Limited, envisages to set up a project with a total outlay of Rs.1850 lakhs for Manufacturing Bulk Drugs namely; Para Hydroxy Phenyl Clycine (PHPC) (totally an Import substitute), Omeprazole, Ciprofloxacin, at Aroor Village, Sadasivpet Mandal, Medak district, A.P. As per the schedule given in the project appraisal, the plant will go into Commercial Production by the end of September, 1995. However, the management is confident of implementing the project ahead of the timeframe given in the implementation schedule and starting Commercial Production by July, 1995, i.e.; 2 months ahead of schedule. 2020 - Everest Organics successfully develops Remdesivir API

Everest Organics Limited, a company with its registered office at Hyderabad, was incorporated on 19th February, 1993. The company has subsequently obtained the certificate of commencement of business on 17th March, 1993. The factory of the company is situated at Aroor Village, Sadasivpet Mandal, Medak district, A.P. The unit is eligible for incentives like State Subsidy, Sales Tax deferment and Power Tariff etc., as the unit is being located in Notified Backward Area. The main objects of the company is to carry on the business of manufacturing, selling of bulk drugs and formulations, which are fully set out in its Memorandum and Articles of Association and are also mentioned below in this prospectus. M/s Everest Organics Limited, envisages to set up a project with a total outlay of Rs.1850 lakhs for Manufacturing Bulk Drugs namely; Para Hydroxy Phenyl Clycine (PHPC) (totally an Import substitute), Omeprazole, Ciprofloxacin, at Aroor Village, Sadasivpet Mandal, Medak district, A.P. As per the schedule given in the project appraisal, the plant will go into Commercial Production by the end of September, 1995. However, the management is confident of implementing the project ahead of the timeframe given in the implementation schedule and starting Commercial Production by July, 1995, i.e.; 2 months ahead of schedule. 2020 - Everest Organics successfully develops Remdesivir API

Parent Organisation

Everest Organics Ltd.

Founded

19/02/1993

Managing Director

Dr.Sri Kakarlapudi Sirisha

NSE Symbol

FAQ